Synthetic molecular probes, chemosensors, and nanosensors used in combination with
innovative assay protocols hold great potential for the development of robust, low-cost, and …

Recent times have witnessed an upsurge in the incidence of neurodegenerative disorders
such as Alzheimer's disease, Parkinson's disease, Huntington's disease, Prion disease, and …

The disruption of pathologically enhanced beta oscillations is considered one of the key
mechanisms mediating the clinical effects of deep brain stimulation on motor symptoms in …

Parkinson's disease (PD) is a neurodegenerative disorder characterized by the loss of
dopaminergic neurons in the Substantia Nigra pars compacta, leading to classical PD motor …

Local field potentials (LFPs) may afford insight into the mechanisms of action of deep brain
stimulation (DBS) and potential feedback signals for adaptive DBS. In Parkinson's disease …

Many conditions can benefit from RNA-based therapies, namely, those targeting internal
ribosome entry sites (IRESs) and their regulatory proteins, the IRES trans-acting factors …

Neurological disorders are the most devastating and challenging diseases associated with
the central nervous system (CNS). The blood-brain barrier (BBB) maintains homeostasis of …

Central nervous system (CNS) diseases, ranging from brain cancers to neurodegenerative
disorders like dementia and acute conditions such as strokes, have been heavily burdening …

The mushroom Agaricus bisporus secretes biologically active compounds and proteins with
benefits for human health. Most reported proteins from A. bisporus are tyrosinases and …

Background Subthalamic (STN) and pallidal (GPi) deep brain stimulation (DBS) improve
quality of life, motor, and nonmotor symptoms (NMS) in advanced Parkinson's disease (PD) …